Found 7 matching trials
A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683 PHASE2 A phase 2, multicenter, uncontrolled, open-label trial in participants with...
Show More Location
Beijing Chest Hospital
Learn More & Join Trial
Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis PHASE2 The purpose of this study is:
* To evaluate the safety and tolerability of...
Show More Location
Infectology Center of Latvia - Clinic of Tuberculosis and Lung Diseases
Learn More & Join Trial
A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) PHASE2 The purpose of this trial is to assess the safety, tolerability, pharmacoki...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis PHASE2 This study evaluated the safety, tolerability, and pharmacokinetics of the ...
Show More Learn More & Join Trial
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy N/A IMPAACT P1026s is a Phase IV prospective clinical study to evaluate the pha...
Show More Location
UAB Pediatric Infectious Diseases CRS
Learn More & Join Trial
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) PHASE3 endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, ...
Show More Location
Aundh Chest Hospital
Learn More & Join Trial
A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) PHASE2 This is a clinical trial to evaluate the safety and efficacy of OPC-67683 i...
Show More Location
University of Texas Health Center at Tyler / Heartland National TB Center / Texas Center for Infectious Disease
Learn More & Join Trial